SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRETTI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.069
EU - Europa 4.834
AS - Asia 3.002
SA - Sud America 91
AF - Africa 17
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.029
IT - Italia 1.827
CN - Cina 1.408
UA - Ucraina 886
SG - Singapore 718
DE - Germania 684
TR - Turchia 644
GB - Regno Unito 344
SE - Svezia 277
PL - Polonia 242
FI - Finlandia 207
ID - Indonesia 113
FR - Francia 101
BR - Brasile 69
RU - Federazione Russa 54
BE - Belgio 37
CA - Canada 32
NL - Olanda 30
ES - Italia 29
IN - India 24
HK - Hong Kong 19
CZ - Repubblica Ceca 18
CH - Svizzera 13
VN - Vietnam 13
LT - Lituania 12
IR - Iran 11
AT - Austria 10
AU - Australia 10
RO - Romania 10
ZA - Sudafrica 10
EU - Europa 9
JP - Giappone 9
EC - Ecuador 8
IE - Irlanda 8
MX - Messico 8
KR - Corea 6
RS - Serbia 6
SM - San Marino 6
AR - Argentina 5
DK - Danimarca 5
PT - Portogallo 5
TH - Thailandia 5
BD - Bangladesh 4
CO - Colombia 4
EE - Estonia 4
AL - Albania 3
HU - Ungheria 3
JO - Giordania 3
LU - Lussemburgo 3
NP - Nepal 3
SA - Arabia Saudita 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
IL - Israele 2
IQ - Iraq 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
SN - Senegal 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZW - Zimbabwe 1
Totale 23.034
Salva come PNG Salva come JPEG
Città #
Fairfield 2.120
Woodbridge 1.929
Jacksonville 1.118
Houston 1.063
Chandler 951
Ashburn 948
Seattle 840
Wilmington 724
Cambridge 718
Santa Clara 700
Ann Arbor 697
Singapore 518
Izmir 462
Nanjing 366
Princeton 284
Dearborn 237
Warsaw 237
Beijing 209
Ferrara 206
San Diego 170
Bremen 162
Milan 155
Boardman 130
Jakarta 111
Nanchang 105
Rome 97
Hebei 83
Falls Church 75
New York 73
Shenyang 71
Tianjin 67
Shanghai 65
Los Angeles 58
Bologna 56
Changsha 52
Jiaxing 51
Redwood City 48
Mountain View 47
Kunming 45
London 42
Orange 40
Jinan 37
Norwalk 37
Naples 35
Brussels 34
Hefei 29
Helsinki 27
Zhengzhou 27
Guangzhou 24
Munich 22
Ningbo 22
San Mateo 22
Turin 21
Florence 19
Verona 18
Chicago 17
Hong Kong 17
Parma 16
Padova 15
Palermo 15
Auburn Hills 14
Indiana 14
Lappeenranta 14
Redmond 14
Reggio Nell'emilia 14
St Petersburg 14
Toronto 14
Taizhou 13
Des Moines 11
Lanzhou 11
Ottawa 11
Torino 11
Brno 10
Catania 10
Changchun 10
Frankfurt am Main 10
Modena 10
Dallas 9
Dong Ket 9
Benevento 8
Foligno 8
Lucca 8
Paris 8
Tappahannock 8
Terni 8
Tokyo 8
Wuhan 8
Amsterdam 7
Ardabil 7
Bolzano 7
Genova 7
Haikou 7
Imola 7
Kilburn 7
Pavia 7
São Paulo 7
Acquaviva 6
Dublin 6
Guayaquil 6
Napoli 6
Totale 16.958
Salva come PNG Salva come JPEG
Nome #
Tumori Odontogeni misti: indagine sul significato delle correlazioni tra fibroma ameloblastico, fibro-odontoma ameloblastico e odontomi. 485
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 384
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 270
Survival of cancer patients in Europe: the EUROCARE study 234
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 224
I tumori in Italia, rapporto 2007: sopravvivenza. 217
I tumori in Emilia-Romagna 216
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 155
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 152
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 147
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 137
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 137
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 135
Completeness and timeliness: Cancer registries could/should improve their performance 134
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 132
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 132
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 132
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 131
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 131
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 129
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 126
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 125
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 125
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 125
International incidence of childhood cancer, 2001-10: a population-based registry study 124
Impatto delle cure palliative sull'assistenza dei pazienti oncologici in fase terminale in provincia di Ferrara nel 2002. 122
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 120
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 120
Survival from salivary glands adenoid cystic carcinoma in European populations 119
Cancer prevalence estimates in Europe at the beginning of 2000 116
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 116
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 116
Application of quantitative analysis to biologic profile evaluation in breast cancer 115
Early (short-interval) rescreen in mammography screening 115
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 115
Regional inequalities in cancer care persist in Italy and can influence survival. 114
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 113
The burden of HPV-related diseases in Italy, 2001-12 113
Epidemiology of rare cancers and inequalities in oncologic outcomes 113
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 113
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 112
Estimates of cancer burden in Emilia-Romagna 112
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 112
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 111
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 111
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 111
Incidence, survival and prevalence of myeloid malignancies in Europe 110
Survival of European patients with central nervous system tumors 110
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. 110
Cancer incidence and mortality trends from 2003 to 2014 in Italy 110
Registro Tumori della provincia di Ferrara 109
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 108
Breast screening: axillary lymph node status of interval cancers by interval year 107
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 107
Estimates of cancer burden in Italy 106
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 106
Treatment challenges in and outside a network setting: Soft tissue sarcomas 106
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 105
Changes in cervical cancer incidence following the introduction of organized screening in Italy 105
Comparative cancer survival information in Europe 105
Estimated and observed cancer incidence in Italy: a validation study. 104
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis 104
null 104
Rare cancers of the head and neck area in Europe 104
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 104
Rare cancers are not so rare: the rare cancer burden in Europe 103
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 102
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 102
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 102
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 102
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 102
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 101
Incidence and survival of rare urogenital cancers in Europe 101
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 101
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 101
Cancer incidence and mortality in the province of Ferrara 1989-1990 100
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 100
An estimate of the number of people in Italy living after a childhood cancer 100
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 100
I programmi di screening oncologici in Emilia-Romagna. I dati dei seminari regionali 2016 100
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 100
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 99
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 99
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 98
null 98
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study 97
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 97
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 97
Rare thoracic cancers, including peritoneum mesothelioma 96
Italy, Ferrara province 95
National estimates of cancer patients survival in italy: A model-based method 95
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project 95
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary 95
Epidemiology of glial and non-glial brain tumours in Europe 95
null 94
null 94
Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project 94
null 93
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 93
null 93
Totale 12.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.838
Totale 116.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.794 0 0 0 0 0 709 549 521 423 340 148 104
2020/20213.526 232 268 274 407 265 314 155 416 179 410 367 239
2021/20222.556 87 296 205 167 129 144 136 195 109 204 188 696
2022/20232.594 313 127 52 267 490 382 61 256 332 34 170 110
2023/20241.428 171 169 60 75 99 125 62 74 44 67 90 392
2024/20252.214 209 148 529 192 733 403 0 0 0 0 0 0
Totale 23.547